MT. ARLINGTON, N.J.--(BUSINESS WIRE)--PDS, a leading global provider of intuitive data management software and solutions for life sciences research, has chosen the Society of Toxicology 2014 Annual Meeting to unveil new products and a new branding campaign that reflects the recent strategic refocusing of the firm.
“As our new branding suggests, we have been making software that works like scientists think for more than 30 years,” said Sayed Badrawi, CEO of PDS. “Our latest products are the ultimate refinement of that concept.”
PDS will be demonstrating Ascentos™, a fully integrated software suite for preclinical research, and TranSEND™, a new FDA submission management solution that automates data translation from multiple sources to produce a single set of harmonized SEND files in compliance with new submission standards. The company will also introduce visitors to Q-Finder®, a powerful bioinformatics data analysis and visualization platform.
“We expect to make a splash at SOT,” said Maro Schuster, senior vice president of business development. “We have breakthrough technology in preclinical data management, and we’re eager to show it to our clients and colleagues.”
Additionally, PDS is sponsoring two sessions at SOT: “New Ways to Optimize Preclinical Workflow” at 1 p.m. March 24 with Laura Kaufman, Ph.D., D.A.B.T.; and “Applying Novel Bioinformatics to Preclinical Data” at 2:45 p.m. March 25, featuring Alexandre Templier, CEO of Quinten, the developer of Q-Finder technology.
With offices on three continents and clients spanning North and South America, Europe and Japan, Swiss-based PDS is a global leader in preclinical data management solutions, with most of the world’s top 10 pharma companies relying on PDS software. For more information on Ascentos and TranSEND, visit Booth 836 at SOT or visit pdslifesciences.com.
For more than 30 years, PDS has provided intuitive data management software and solutions for life sciences research and development programs worldwide. Most of the world’s top 10 pharma companies rely on PDS software, as do industry-leading CROs, chemical companies, universities and regulatory agencies. The PDS software lineup is centered on Ascentos™, your integrated preclinical software solution, which is purpose-built to support toxicology, clinical pathology, reproductive toxicology and pathology. PDS also offers TranSEND™, your complete FDA submission management solution, as well as powerful bioinformatics analysis and other services. Learn more at pdslifesciences.com.